Smith, R.M.; Kempfert, K.D.: A'-3,4-cis-tetrahydrocannabinol in Cannabis 
sativa. Phytochemistry 16:1088-1089, 1977. 
Sofia, R.D.; Solomon, T.A.; Barry, H., II]: The anticonvulsant activity of 
delta-1-tetrahydrocannabinol in mice. Pharmacologist 13:246, 1971. 
Sofia, R.D.; Nalepa, S.D.; Vassar, H.B.; et al.: Comparative antiphlogistic 
activity of delta-9-tetrahydrocannabinol, hydrocortisone and aspirin in 
various rat paw edema models. Life Sci. 12:251, 1974. 
Stafford, P.: Psychedelics Encyclopedia, And/or Press, Berkeley, Cal., 1977. 
Stahel, G.: De Nuttige Planten van Suriname. Bulletin No. 59, Dept. Land- 
bouwproef-station, Suriname, 1944. 
Stahl, E.; Kunde, R.: Neue Inhaltsstoffe aus dem Atherischen Ol von Cannabis 
sativa. Tetrahedron Lett. 1973:2841-2844. 
St. Angelo, A.J.S.; Ory, R.L.; Hansen, H.J.: Properties of a purified pro- 
teinase from hempseed. Phytochemistry 9:1933-1938, 1969. 
St. Angelo, A.J.S.; Yatsu, L.Y.; Altschul, A.M.: Isolation of edestin from 
aleurone grains of Cannabis sativa. Arch. Biochem. 124:199-205, 1968. 
Stamets, P.: Psilocybe Mushrooms and their Allies, Homestead Book Co., 
Seattle, 1978. 
Staud, H.: Uber die chemischen Bestandteile der Mandragorawirzel. 2. Die 
Alkaloide. Helv. Chim. Acta 45:2297-2305, 1962. 
Stefanis, C.; Dornbush, R.; Fink, M.: Hashish. Studies of Long-term Use, 
Raven Press, New York, 1977. 
Stepanova, I.V.: Fatty acid composition of lipids of new hemp varieties. 
Prikl. Biokhim. Mikrobiol. 9:323-325, 1973. Through Chemical Ab- 
stracts 79:2742y. 
Stockwell, D.M.; Dechary, J.M.; Altschul, A.M.: Chromatography of edestin 
at 50°. Biochem. Biophys. Acta 82:221, 1964. 
Stromberg, L.: Minor components of Cannabis resin. VI. Mass spectrometric 
data and gas-chromatographic retention times of terpenic components 
with retention times shorter than that of cannabidiol. J. Chromatogr. 
96:99-114, 1974. 
Strémberg, L.: Minor components of Cannabis resin. IV. Mass spectrometric 
data and gas chromatographic retention times of components eluted 
after cannabinol. J. Chromatogr. 121:313-322, 1976. 
Stueck, G.S.: Marihuana: review. Can. Pharm. J. 112:126-127, 134, 1979. 
Taber, W.A.; Heacock, R.A.: Location of ergot alkaloids and fungi in the seed 
of Rivea corymbosa (L.) Hall. f., “Ololiuqui”. Can. J. Microbiol. 8:137- 
143, 1962. 
Taber, W.A.; Heacock, R.A.; Mahon, M.E.: Ergot-type alkaloids in vegetable 
tissueof Rivea corymbosa (W.) Hall. f. Phytochemistry 2:99-101, 1963. 
Taber, W.A.; Vining, L.C.; Heacock, R.A.: Clavine and lysergic acid alkaloids 
in varieties of morning glory. Phytochemistry 2:65-70, 1963. 
Tannhauser, M.; Izquierdo, I.: Effect of seizures and anticonvulsant agents on 
hippocampal RNA concentration. Pharmacology 11:139-145, 1974. 
Truitt, E.B. Jr.; Callaway, E., III.; Braude, M.; et al.: The pharmacology of 
myristicin. Contribution to the psychopharmacology of nutmeg. J. 
Neuropsychiatry 2:205-210, 1961. 
Turkanis, S.A.; Cely, W.; Olsen, D.M.; et al.: Anticonvulsant properties of 
canuabidiol. Res. Commun. Chem. Path. Pharmacol. 8:231-246, 1974. 
211 
